Plus Therapeutics, Inc.
Plus Therapeutics, Inc.（PSTV）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PSTV · 截至 2026年6月9日
活动摘要
买入笔数
2
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Plus Therapeutics, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
PSTV 季度内部人买卖趋势
PSTV 内幕交易卖出 · PSTV 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · PSTV CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
PSTV 高管卖出股份 · PSTV 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 1, 2026 | Sims Andrew John Hugh MacIntyre CFO | Option | 29,129 | — | Form 4 |
| Apr 1, 2026 | Sims Andrew John Hugh MacIntyre CFO | Option | 38,323 | — | Form 4 |
| Apr 1, 2026 | HEDRICK MARC H CEO · Director | Option | 201,632 | — | Form 4 |
| Apr 1, 2026 | HEDRICK MARC H CEO · Director | Option | 159,681 | — | Form 4 |
| Jan 1, 2026 | HEDRICK MARC H CEO · Director | Option | 159,681 | — | Form 4 |
| Jan 1, 2026 | Sims Andrew John Hugh MacIntyre CFO | Option | 38,323 | — | Form 4 |
| Nov 4, 2025 | Sims Andrew John Hugh MacIntyre CFO | Purchase | 20,000 | $10K | Form 4 |
| Oct 1, 2025 | HEDRICK MARC H CEO · Director | Option | 159,681 | — | Form 4 |
| Oct 1, 2025 | Sims Andrew John Hugh MacIntyre CFO | Option | 38,323 | — | Form 4 |
| Aug 22, 2025 | Lenk Robert P Director | Purchase | 110,000 | $54K | Form 4 |
| Sep 13, 2024 | Hawkins Richard J Director | Purchase | 4,000 | $6K | Form 4 |
| Sep 12, 2024 | Hawkins Richard J Director | Purchase | 6,285 | $9K | Form 4 |
| Sep 11, 2024 | Petersen Greg Director | Purchase | 12,500 | $17K | Form 4 |
| Sep 11, 2024 | Clowes Howard Director | Purchase | 5,000 | $7K | Form 4 |
| Sep 10, 2024 | HEDRICK MARC H CEO · Director | Purchase | 8,000 | $10K | Form 4 |
| Sep 10, 2024 | Sims Andrew John Hugh MacIntyre CFO | Purchase | 4,098 | $5K | Form 4 |
| May 8, 2024 | Sims Andrew John Hugh MacIntyre CFO | Purchase | 4,902 | $10K | Form 4 |
| May 8, 2024 | HEDRICK MARC H CEO · Director | Purchase | 12,255 | $25K | Form 4 |
| May 8, 2024 | Petersen Greg Director | Purchase | 12,255 | $25K | Form 4 |
| May 8, 2024 | Clowes Howard Director | Purchase | 9,804 | $20K | Form 4 |
| May 8, 2024 | Hawkins Richard J Director | Purchase | 4,902 | $10K | Form 4 |
| May 8, 2024 | Lenk Robert P Director | Purchase | 4,167 | $9K | Form 4 |
| Nov 20, 2023 | HEDRICK MARC H CEO · Director | Sale | 2,068 | $4K | Form 4 |
| Nov 16, 2023 | Lenk Robert P Director | Purchase | 1,000 | $2K | Form 4 |
| Nov 15, 2023 | Lenk Robert P Director | Purchase | 1,000 | $2K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PSTV 内幕交易
PSTV 内幕交易
Plus Therapeutics, Inc.（PSTV）内幕交易数据来源于公司内部人（包括Sims Andrew John Hugh MacIntyre (CFO), HEDRICK MARC H (CEO · Director), Lenk Robert P (Director)）提交的SEC Form 4申报文件。过去12个月内，3位内部人向SEC提交了交易申报。PSTV内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Plus Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PSTV 内幕交易 · 5个问题Plus Therapeutics, Inc.（PSTV）的内部人包括高管和董事，如Sims Andrew John Hugh MacIntyre (CFO), HEDRICK MARC H (CEO · Director), Lenk Robert P (Director)等。过去12个月内，3位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026